6699 related articles for article (PubMed ID: 24649192)
1. Systemic administration of attenuated
Wang Y; Chen J; Tang B; Zhang X; Hua ZC
Mol Clin Oncol; 2013 May; 1(3):461-465. PubMed ID: 24649192
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the selective targeting efficacy of Salmonella typhimurium A1-R and VNP20009 on the Lewis lung carcinoma in nude mice.
Zhang Y; Zhang N; Zhao M; Hoffman RM
Oncotarget; 2015 Jun; 6(16):14625-31. PubMed ID: 25714030
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral injection of schwannoma with attenuated
Ahmed SG; Oliva G; Shao M; Wang X; Mekalanos JJ; Brenner GJ
Proc Natl Acad Sci U S A; 2022 Jun; 119(24):e2202719119. PubMed ID: 35675425
[TBL] [Abstract][Full Text] [Related]
4. Effect of Antibiotic Treatment on Attenuated
Ahmed SG; Brenner GJ
Anticancer Res; 2023 Jan; 43(1):1-6. PubMed ID: 36585175
[TBL] [Abstract][Full Text] [Related]
5. Culture of attenuated
Ahmed SG; Oliva G; Shao M; Mekalanos JJ; Brenner GJ
Hum Vaccin Immunother; 2023 Aug; 19(2):2262639. PubMed ID: 37786375
[TBL] [Abstract][Full Text] [Related]
6. A phase I trial of genetically modified Salmonella typhimurium expressing cytosine deaminase (TAPET-CD, VNP20029) administered by intratumoral injection in combination with 5-fluorocytosine for patients with advanced or metastatic cancer. Protocol no: CL-017. Version: April 9, 2001.
Cunningham C; Nemunaitis J
Hum Gene Ther; 2001 Aug; 12(12):1594-6. PubMed ID: 11529249
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of acute leukemia with attenuated Salmonella typhimurium strain VNP20009.
Li M; Lu M; Lai Y; Zhang X; Li Y; Mao P; Liang Z; Mu Y; Lin Y; Zhao AZ; Zhao Z; Zhou S; Li F
Biomed Pharmacother; 2020 Sep; 129():110425. PubMed ID: 32570123
[TBL] [Abstract][Full Text] [Related]
8. Tumor-targeting Salmonella typhimurium, a natural tool for activation of prodrug 6MePdR and their combination therapy in murine melanoma model.
Chen G; Tang B; Yang BY; Chen JX; Zhou JH; Li JH; Hua ZC
Appl Microbiol Biotechnol; 2013 May; 97(10):4393-401. PubMed ID: 22868826
[TBL] [Abstract][Full Text] [Related]
9. Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma.
Toso JF; Gill VJ; Hwu P; Marincola FM; Restifo NP; Schwartzentruber DJ; Sherry RM; Topalian SL; Yang JC; Stock F; Freezer LJ; Morton KE; Seipp C; Haworth L; Mavroukakis S; White D; MacDonald S; Mao J; Sznol M; Rosenberg SA
J Clin Oncol; 2002 Jan; 20(1):142-52. PubMed ID: 11773163
[TBL] [Abstract][Full Text] [Related]
10. Microwave ablation combined with attenuated Salmonella typhimurium for treating hepatocellular carcinoma in a rat model.
Zhao Q; Qu X; Liu K; Shi H; Yang G; Zhou B; Zhu L; Zhang W; Yan Z; Liu R; Qian S; Wang J
Oncotarget; 2017 Jul; 8(29):47655-47664. PubMed ID: 28498813
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effect of VNP20009, an attenuated Salmonella, in murine tumor models.
Luo X; Li Z; Lin S; Le T; Ittensohn M; Bermudes D; Runyab JD; Shen SY; Chen J; King IC; Zheng LM
Oncol Res; 2001; 12(11-12):501-8. PubMed ID: 11939414
[TBL] [Abstract][Full Text] [Related]
12. Oral delivery of tumor-targeting Salmonella for cancer therapy in murine tumor models.
Jia LJ; Wei DP; Sun QM; Huang Y; Wu Q; Hua ZC
Cancer Sci; 2007 Jul; 98(7):1107-12. PubMed ID: 17498202
[TBL] [Abstract][Full Text] [Related]
13. Salmonella-mediated tumor-targeting TRAIL gene therapy significantly suppresses melanoma growth in mouse model.
Chen J; Yang B; Cheng X; Qiao Y; Tang B; Chen G; Wei J; Liu X; Cheng W; Du P; Huang X; Jiang W; Hu Q; Hu Y; Li J; Hua ZC
Cancer Sci; 2012 Feb; 103(2):325-33. PubMed ID: 22054098
[TBL] [Abstract][Full Text] [Related]
14. Toxicology and efficacy of tumor-targeting
Zhang Y; Cao W; Toneri M; Zhang N; Kiyuna T; Murakami T; Nelson SD; Dry SM; Li Y; Li S; Wang X; Ma H; Singh AS; Eilber FC; Hoffman RM; Zhao M
Oncotarget; 2017 Aug; 8(33):54616-54628. PubMed ID: 28903369
[No Abstract] [Full Text] [Related]
15. Antitumor mechanisms of attenuated Salmonella typhimurium containing the gene for human interleukin-2: a novel antitumor agent?
Saltzman DA; Katsanis E; Heise CP; Hasz DE; Vigdorovich V; Kelly SM; Curtiss R; Leonard AS; Anderson PM
J Pediatr Surg; 1997 Feb; 32(2):301-6. PubMed ID: 9044141
[TBL] [Abstract][Full Text] [Related]
16. Suppression of pancreatic ductal adenocarcinoma growth by intratumoral delivery of attenuated Salmonella typhimurium using a dual fluorescent live tracking system.
Zhou S; Zhao Z; Lin Y; Gong S; Li F; Pan J; Li X; Gao Z; Zhao AZ
Cancer Biol Ther; 2016 Jul; 17(7):732-40. PubMed ID: 27089121
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effects of arsenic trioxide combined with
Zhao Q; Wang Y; Li WT
J Gastrointest Oncol; 2021 Aug; 12(4):1732-1742. PubMed ID: 34532123
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Anticancer Activities and Biosafety Between
Liu X; Guo Y; Sun Y; Chen Y; Tan W; Min JJ; Zheng JH
Front Microbiol; 2022; 13():914575. PubMed ID: 35847095
[No Abstract] [Full Text] [Related]
19. Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium.
Clairmont C; Lee KC; Pike J; Ittensohn M; Low KB; Pawelek J; Bermudes D; Brecher SM; Margitich D; Turnier J; Li Z; Luo X; King I; Zheng LM
J Infect Dis; 2000 Jun; 181(6):1996-2002. PubMed ID: 10837181
[TBL] [Abstract][Full Text] [Related]
20. Recombinant attenuated Salmonella typhimurium carrying a plasmid co-expressing ENDO-VEGI151 and survivin siRNA inhibits the growth of breast cancer in vivo.
Li Z; Yin PH; Yang SS; Li QY; Chang T; Fang L; Shi LX; Fang GE
Mol Med Rep; 2013 Apr; 7(4):1215-22. PubMed ID: 23404494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
